Technology News

CorMedix Receives Catheter Lock Solution CE Mark

Monday, July 08, 2013 5:01:00 AM PDT | VentureDeal

   Bridgewater, New Jersey  --  CorMedix (NYSE: DRMD) announced that it has garnered a European CE Mark for its catheter lock solution.

Called Neutrolin, the solution includes a combination of an anti-coagulant and broad-spectrum antimicrobial for use in central venous catheters on hemodialysis secondary to advanced chronic kidney disease sufferers.

Neutrolin is a Class III device and the designation enables CorMedix to market the device across all European Union member countries that have adopted the Medical Devices Directive.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1